Reliability and validity of Turkish version of COPD Assessment Test;KOAH deǧerlendirme testinin Türkçe geçerlilik ve güvenilirliǧi

Tuberkuloz ve Toraks

Volumn 60, Issue 4, 2012, Pages 314-320

  Yorgancioǧlu, Arzu ^a   Polatli, Mehmet ^b   Aydemir, Ömer ^a   Yilmaz Demirci, Nilgün ^c   Kirkil, Gamze ^d   Nayci Atiş, Sibel ^e   Kokturk N ^f   Uysal, Atilla ^g   Akdemir, Selim Erkan ^a   Özgür, Eylem Sercan ^e   Günakan, Gonca ^f  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

^c Ataturk Chest Disease and Thoracic Surgery Education and Research Hospital Ankara   (Turkey)

^d FIRAT UNIVERSITY   (Turkey)

^e MERSIN UNIVERSITY   (Turkey)

^f GAZI UNIVERSITY   (Turkey)

^g OKMEYDANI TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

CAT; COPD; Reliability; Validity

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREATHLESSNESS COUGH SPUTUM SCALE; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; FEMALE; HUMAN; INTERNAL CONSISTENCY; ITEM TOTAL CORRELATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA INDEX; PRESCHOOL CHILD; SHORT FORM 36; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TEST RETEST RELIABILITY; TURKISH VERSION OF CHRONIC OBSTRUCTIVE LUNG DISEASE ASSESSMENT TEST;

EID: 84872183176     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: 10.5578/tt.4321     Document Type: Article

References (13)

1. GOLD Committee. Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Initiative for Chronic Obstructive Lung Disease website. http://www.goldcopd.org/guidelines-global-strategy-for-diagnosismanagement.html. Updated December 2011. Accessed February 20, 2012.
2. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34: 648-54.
3. Erdinc E, Polatli M, Kocabas A, Yi{dotless}ldi{dotless}ri{dotless}m N, Gurgun A, Saryal S, et al. Turkish Thoracic Society Chronic Obstructive Pulmonary Disease Diagnosis and Treatment Consensus Guidelines. Türk Toraks Dergisi 2010; 11: 1-64.
4. Jones PW, Agusti AGN. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 822-32.
5. Mahler DA, Criner GJ. Assessment tools for chronic obstructive pulmonary disease. Do newer metrics allow for disease modification. Proc Am Thorac Soc 2007; 4: 507-11.
6. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11: 122.
7. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs. disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999; 116: 1632-7.
8. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-40.
9. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56: 880-7.
10. Jones PW, Carone M. Health status "quality of life". Eur Respir Mon 2000; 13: 22-35.
11. Jones P, Harding G, Wiklund I, Berry P, Leidy N. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J 2009; 18: 208-15.
12. Dodd JW, Hogg L, Nolan J, Jefford H, Grant A, Lord VM, et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax 2011; 66: 425-9.
13. Tsuda T, Suematsu R, Kamohara K, Kurose M, Arakawa I, Tomioka R, et al. Development of the Japanese version of the COPD Assessment Test. Respir Investig 2012; 50: 34-9.